P ercutaneous epicardial access (EA) has become an increasingly important step for mapping and ablating complex ventricular arrhythmias and also for the left atrial appendage exclusion using an epicardial ligation system like the Lariat device (Lariat). 1 EA using the subxiphoid approach can be challenging and is associated with a low but definite incidence of major complications including pericardial effusion from right and left ventricular puncture resulting in tamponade, pleuro-pericardial fistula, coronary artery or vein laceration, and visceral injury among others. The cumulative incidence of these complications has ranged from 6% to 25% in some case series. 2-4 Pericarditis seems to be most common complication occurring in the majority of the patients. The incidence of right ventricular myocardial puncture ranges from 4.5% to 17% using the subxiphoid approach. 5,6 Despite this higher incidence of myocardial puncture, the incidence of myocardial tear or pericardial effusion requiring open surgery is relatively low. This difference in the incidence of myocardial puncture and large pericardial effusion may be related to the auto closure of the myocardial puncture site. Conventionally
used needles like the Tuohy and Pajunk are large bore (LB) and 18G needles. It is possible that the relatively large tip of these LB needles have contributed, at least in part, to the many of the above complications. 7 The thin bore (21G) micropuncture (MP) needle ( Figure 1 ) is increasingly used in cardiac interventions for routine vascular access to prevent major vascular complications. The smaller tip of the MP needle probably explains why damage to the vascular and surrounding structures could be relatively more forgiving. Observational studies suggest that MP needles may be better than LB needles in minimizing postprocedural vascular complications and randomized trials are underway. 8 However, there are no data in the literature comparing the use of MP needle versus LB needle for EA procedures.
We sought to compare the procedural complications during EA associated with use of MP needle versus LB needle. We hypothesize that the use of MP needle will decrease the EA-related complications compared with LB needle.
Materials and Methods
We performed a multicenter observational study of all consecutive patients undergoing EA either for ablation of ventricular tachycardia (VT) or left atrial appendage exclusion using the Lariat from January 2010 to June 2014 at the participating institutions. The study was approved by the institutional review board. Baseline demographics, laboratory parameters, procedural characteristics, and complications were collected and analyzed.
Oral anticoagulation was stopped 5 days before the procedure. Patients undergoing Lariat procedure were bridged with low molecular weight heparin with the last dose held on the morning of the procedure. Preprocedural cardiac imaging was mandated for all patients undergoing the Lariat procedure to assess the left atrial appendage anatomy but was used to evaluate the chest and cardiac anatomy.
Epicardial Access
EA was performed as per standard of practice as described previously by Sosa et al. 9 A dry intrapericardial access was obtained through a subxiphoidal pericardial puncture (2 finger breadths below the tip of the xiphoid; Figures 2 and 3) The needle was angled at 20° to 30° advanced into the pericardial space while aiming toward the left midclavicle at the cardiac border under fluoroscopic guidance. The angle entry was adjusted according to whether an anterior or posterior approach is preferred. Puncturing the pericardial space was performed under negative pressure to confirm pericardial puncture from right ventricular puncture. An 18-gauge epidural introducer needle (Tuohy or Pajunk needle) was used in the LB needle group, where as a 21G MP needle was used in the MP needle group. In MP needle group, when significant subcutaneous tissue was encountered which was making the needle bend, a short LB needle was used to support the MP through the subcutaneous tissue (telescoping approach). Care was taken not to advance the 18G needle beyond the subcutaneous tissue. The entry of the needle into the pericardium was always performed in the left lateral view.
Subsequently, contrast medium was injected to demonstrate the position of the needle tip, and a J-tipped, floppy guidewire of 0.018″ and 60 cm in length was then introduced through the needle until its tip was free within the pericardial space. A 15-cm long sheath was advanced into the pericardial space over the guidewire to enable aspiration of pericardial fluid and delivery of the ablation catheter to the epicardial surface of the atrium and ventricle.
A tactile sensation of puncture through the pericardium, generally sought with the LB needle, was not routinely perceptible with the MP needle. A 0.18-inch long wire was placed and exchanged to a larger sheath subsequently. Pericardial access was performed under transesophageal guidance for patients undergoing Lariat procedure or intracardiac echocardiography to assess for ventricular puncture and pericardial effusion.
Procedural Complications
Complications of the procedure were assessed and recorded in the registry prospectively. Pericardial access-related complications were divided into major and minor. Major complications include large pericardial effusions causing tamponade, drainage, blood transfusions, open heart surgery for the cardiac repair, abdominal exploration, and repair. Minor complication includes inadvertent puncturing of the right ventricular (RV) myocardium.
Large pericardial effusion (with or without cardiac tamponade) was defined as accumulation of >500 mL of fluid in the pericardial space. Inadvertent myocardial puncture was defined as accidental penetration of myocardium with the EA needle leading to entry of needle into the ventricular chamber or myocardium (as identified by intracardiac contrast or myocardial staining, respectively) with or without significant pericardial effusion, without need for open heart surgery, and without the need for stopping the procedure. Pericardial drain was placed post procedure for all patients and left in place 12 to 24 hours or until the pericardial effusion was <50 mL over a period of 4 hours in all patients.
WHAT IS KNOWN
• Percutaneous epicardial access is used for some ablation and left atrial appendage closure procedures.
• Studies using conventional large bore 18-gauge needles for percutaneous epicardial access report an incidence of major complications, most commonly pericardial bleeding, some from right ventricular puncture, of 6% to 25%.
WHAT THE STUDY ADDS
• In this observational study, the use of a 21-gauge micropuncture needle for epicardial access was associated with fewer large periprocedural pericardial effusions.
• Use of a micropuncture needle should be routinely considered for epicardial access. . The lower most image shows that the long MP needle is introduced through the large short needle in a telescoping approach.
Statistical Analysis
Continuous variables are expressed as mean±SD. Categorical variables were presented as proportions. Categorical variables which are normally distributed were analyzed using χ 2 test and Fischer's exact test whenever appropriate. Continuous variables which are normally distributed were analyzed using independent sample t test and those non-normally distributed were analyzed using the Mann-Whitney U test. Logistic regression analysis was used to assess for the predictors of outcomes. All statistics were performed using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp, Armonk, NY). A P value of <0.05 was considered as statistically significant.
Results
A total of 404 (185 with LB and 219 with MP needle) consecutive patients underwent EA for VT ablation (N=91) and the Lariat procedure (N=313) at participating institutions and were included in the current study. Of the 185 (45%) patients, who had EA performed using a LB needle, 54 (29%) patients had VT ablation and 131 (71%) patients had the Lariat procedure. Of the 219 (55%) patients, who had EA performed using a MP needle, 37 (17%) patients underwent VT ablation and 182 (83%) of patients underwent the Lariat procedure. All patients who underwent Lariat procedure had anterior EA and 60 (63%) patients undergoing VT ablation underwent posterior EA. Baseline characteristics are compared between the LB and MP needle groups in Table 1 . Both the groups were similar in the distribution of baseline characteristics and medication use.
The incidence of large pericardial effusions was significantly higher in LB needle when compared with MP needle group (15/8.1% versus 2/0.9%, P<0.001). The trend was similar for both the types of procedures. The incidence of large pericardial effusions were higher with the use of LB needle versus MP needle in patients undergoing Lariat procedure (8/6.1% versus 1/0.5%; P=0.005) and in patients undergoing VT ablation (7/13% versus 1/2.7%; P=0.13; Table 2 ). The incidence of pleural effusions was not significantly different with the 2 needle groups (3/1.6% versus 5/2.3%, P=0.64 with LB versus MP needle, respectively). Injury to liver (n=1) and left anterior descending coronary artery (n=1) occurred in patients in the LB needle group, whereas injury to the superior epigastric artery injury (n=1) occurred in the MP needle group (0 versus 1). Patient with liver injury underwent laparotomy to drain the subcapsular hematoma. Patient with coronary artery injury underwent coronary angiogram followed by placement of covered stent. Patient with superior epigastric artery injury underwent drainage of rectus sheath hematoma with ligation of injured vessel (Data Supplement for details). The incidence of pericardial and pleural effusion effusions was not significantly different in the anterior versus posterior EA.
Minor complications in the form of inadvertent RV myocardial entry was seen frequently with both LB and MP needles (14/7.6% versus 15/6.8%; P=0.76, respectively). Of the 14 patients who had inadvertent myocardial puncture in the LB needle group, 6 patients needed surgical repair. Of the 15 patients in the MP needle group, none required surgical repair.
On multivariate regression analysis after adjusting for other measured variable, the use of MP needle was associated with 91% decrease in development of large pericardial effusions (odds ratio, 0.09; confidence interval, 0.011-0.729; P=0.02; Table 3 ). 
Discussion

Study Findings
In our large, multicenter study, we report that the use of MP needle for EA for interventional pericardial procedures is associated with a decreased risk of large pericardial effusions and subsequent need of surgical repair when compared with using conventional LB needle. Inadvertent myocardial injury is common with both needles; however, the injury from the MP needle seems to be more forgiving. To the best of our knowledge, there have been no studies in the literature evaluating the safety and efficacy of MP needle when compared with the LB needle.
EA is being increasingly performed for interventional electrophysiology procedures. Conventionally, EA has been performed with Tuohy needle (Tuohy bevel, 18 gauge, 1.3×80 or 150 mm; Braun, Kronberg, Germany) designed to enter virtual spaces or with Pajunk needle (Pajunk Medical Systems, Norcross, GA) in patients undergoing VT ablation. The complications rate with EA has been one of the major limiting factors in performing these procedures. Sacher et al 5 reported a complication rate of 9% in 156 patients undergoing EA with LB needle and the RV puncture accounted for 5% of cases, whereas Della Bella et al 10 reported a complication rate of 4.1% in 218 patients at 6 European centers over a period of 8 years. 5 Large pericardial effusion and consequent tamponade are the most feared complications and can be devastating if not emergently treated with frequent draining or with surgical repair. 11 In a single-center study by Tung et al, 12 major complications were seen in 8.8% of the patients, and epicardial bleeding from RV puncture seems to be the major complication. Inadvertent RV puncture ranged from 4.5% to 17% of the cases but majority of these cases had <80 mL pericardial bleeding without serious consequences. Pericardial effusions associated with the epicardial access and the ligation of the appendage using the Lariat causes intense inflammation leading to significant amounts of serosanguineous rather than hemorrhagic effusions. In such cases even if some small amount of blood would make the effusion appear bloody, making it difficult to assess the actual amount of bleeding. We wanted to use a volume which was clinically more relevant. In contrary to previous studies where pericardial bleeding of >80 mL was considered large/significant, we have considered >500 mL of bloody effusion significant enough to either intervene or delay the drain removal and therefore considered them as large pericardial effusions. Although we had few patients with smaller (<500 mL) pericardial effusions, most of these effusions were not clinically significant and none of the patients needed transfusions or additional interventions. Unfortunately, we did not consistently collect effusion data when the effusions were smaller or intermediate in all the participating centers.
Newer 21G MP needle is 7 to 15 cm in length developed by cook medicals (Bloomington, IN) used for placement of 0.014-and 0.018-inch diameter wire guides into the vascular systems used initially for the femoral arterial access during cardiac catheterization or subclavian/axillary vein access during cardiac device placement to minimize the vascular complications and other related collateral damage. MP needle is much smaller at the tip with a smooth shaft to tip transition eliminating hang-ups during the access and is believed to be associated with less trauma during access. Ambrose et al 13 compared the LB needle with MP needle in patients undergoing cardiac catheterization through femoral arterial access and reported a significantly higher vascular event rate using the LB when compared with a MP needle (15.5% versus 9.4%). 14 A dry EA (as needed to VT ablation and Lariat procedures) is different and much more challenging when compared with EA for draining an existing large pericardial effusion. During an EA to drain a large pericardial effusion, the EA needle traverses the soft tissue beneath the sternum and enters the tough pericardium resulting in a sudden "give in" that is safely buffered by the pericardial fluid. However, during a dry EA, the safety buffer does not exist and often times the needle inadvertently overshoots into the RV causing some trauma to the myocardium. Despite the complexity of EA and severity of the associated complications, there have not been significant strides in minimizing the complications of EA.
The resistance at the tip of the LB needle is significantly higher than a small bore MP needle while penetrating a tough pericardial tissue. This obviously requires a higher force to facilitate the entry of the needle across the pericardial tissue force required to enter a tough pericardium is much higher for a LB (greater surface area) needle compared with a micro puncture (lesser surface area). This perhaps explains the reason why a MP needle can be advanced through the pericardium with less force and torque, in a more controlled fashion when compared with an LB needle. The shearing forces of a MP needle on the RV wall are probably lower than a LB needle. Even if there was an inadvertent entry of the RV wall by the MP needle, the likelihood of auto seal is probably higher than that caused by a LB needle. This is supported by our study findings that despite having a similar incidence of inadvertent RV puncture, major complications were significantly lower when a MP needle was used for EA. With the current increase in the number of procedures requiring EA, any improvement in the safety of the procedure, as demonstrated in our study by the use of MP needle with or without telescoping approach, would have a positive impact on the learning curve of newer operators. In large patients with significant abdominal soft tissue, the outer shorter LB needle provides support and through this a long MP needle can be advanced safely without bending facilitating a safer pericardial access.
Clinical Implications
EA-related complications while performing VT or Lariat procedures can be devastating. Use of MP needle instead of conventional LB needle can decrease the incidence of periprocedural large pericardial effusions and the requirement for surgical repair. Operators should probably consider using a MP needle for EA to improve the safety profile of the procedure routinely.
Study Limitations
Our is an observational multicenter study with its inherent limitations. The use of the type of needles was operator dependent and not randomized. However, it is a fairly large, multicenter study with well-balanced groups. A randomized study comparing the 2 types of needles may not be really necessary to appreciate the value of a less traumatic MP needle.
Conclusions
In our multicenter, observational study, we found that for obtaining EA, the use of MP needle is associated with a significantly decreased risk of periprocedural large pericardial effusions and subsequent surgical repair when compared with the conventional LB needle. MP needle should be routinely considered for EA access to minimize these major complications. 
